VIENNA — Physicians are called to record clinical details of patients with asthma undergoing biologic therapy to monitor clinical remission and keep an eye on eosinophilic […]

VIENNA — Simply relying on clinical symptoms is insufficient to predict which children with wheezing will develop asthma and respond to treatments. More objective tests like […]

VIENNA — Survival rates at 1 and 5 years for patients with pulmonary arterial hypertension (PAH) who receive bilateral lung and heart-lung transplants are similar, said […]

Malnutrition, very severe airway obstruction, and the presence of three or more comorbidities were significant predictors of 180-day readmission for older adults with chronic obstructive pulmonary […]

VIENNA — Advances in genetic testing and newly discovered biomarkers can help screen newborns and monitor inflammation and pulmonary exacerbations in patients diagnosed with cystic fibrosis. […]

VIENNA — The optimal course of treatment when managing acute, high-risk pulmonary embolism (PE) remains a contentious topic among respiratory specialists. Systemic thrombolysis, specifically using recombinant […]

VIENNA — At the European Respiratory Society (ERS) 2024 Congress, experts discussed the benefits and risks of artificial intelligence (AI) in medicine and explored ethical implications and […]

Over the past few years, osimertinib has received much fanfare among lung cancer experts.  Results from the phase 3 LAURA trial were met with a standing […]

Evidence that White patients with lung disease are disproportionately more likely to get a lung transplant compared with minority populations hasn’t shifted much in recent years. […]